| Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction JG Abelin, DB Keskin, S Sarkizova, CR Hartigan, W Zhang, J Sidney, ... Immunity 46 (2), 315-326, 2017 | 584 | 2017 |
| MHC class I–associated phosphopeptides are the targets of memory-like immunity in leukemia M Cobbold, H De La Peña, A Norris, JM Polefrone, J Qian, AM English, ... Science translational medicine 5 (203), 203ra125-203ra125, 2013 | 232 | 2013 |
| Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction JG Abelin, D Harjanto, M Malloy, P Suri, T Colson, SP Goulding, ... Immunity 51 (4), 766-779. e17, 2019 | 203 | 2019 |
| Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry JG Abelin, PD Trantham, SA Penny, AM Patterson, ST Ward, ... Nature protocols 10 (9), 1308-1318, 2015 | 114 | 2015 |
| Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs S Weingarten-Gabbay, S Klaeger, S Sarkizova, LR Pearlman, DY Chen, ... Cell 184 (15), 3962-3980. e17, 2021 | 109 | 2021 |
| Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes JG Abelin, J Patel, X Lu, CM Feeney, L Fagbami, AL Creech, R Hu, D Lam, ... Molecular & Cellular Proteomics 15 (5), 1622-1641, 2016 | 100 | 2016 |
| A library of phosphoproteomic and chromatin signatures for characterizing cellular responses to drug perturbations L Litichevskiy, R Peckner, JG Abelin, JK Asiedu, AL Creech, JF Davis, ... Cell systems 6 (4), 424-443. e7, 2018 | 76 | 2018 |
| Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes DB Graham, C Luo, DJ O’Connell, A Lefkovith, EM Brown, M Yassour, ... Nature medicine 24 (11), 1762-1772, 2018 | 74 | 2018 |
| Specter: linear deconvolution for targeted analysis of data-independent acquisition mass spectrometry proteomics R Peckner, SA Myers, ASV Jacome, JD Egertson, JG Abelin, MJ MacCoss, ... Nature methods 15 (5), 371-378, 2018 | 69 | 2018 |
| The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction AL Creech, YS Ting, SP Goulding, JFK Sauld, D Barthelme, MS Rooney, ... Proteomics 18 (12), 1700259, 2018 | 62 | 2018 |
| Optimized liquid and gas phase fractionation increases HLA-peptidome coverage for primary cell and tissue samples S Klaeger, A Apffel, KR Clauser, S Sarkizova, G Oliveira, S Rachimi, ... Molecular & Cellular Proteomics 20, 2021 | 37 | 2021 |
| Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations J Choi, SP Goulding, BP Conn, CD McGann, JL Dietze, J Kohler, ... Cell reports methods 1 (5), 2021 | 30 | 2021 |
| SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs S Weingarten-Gabbay, S Klaeger, S Sarkizova, LR Pearlman, DY Chen, ... bioRxiv, 2020.10. 02.324145, 2020 | 27 | 2020 |
| MS-based HLA-II peptidomics combined with multiomics will aid the development of future immunotherapies HB Taylor, S Klaeger, KR Clauser, S Sarkizova, S Weingarten-Gabbay, ... Molecular & Cellular Proteomics 20, 2021 | 16 | 2021 |
| Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues JG Abelin, EJ Bergstrom, KD Rivera, HB Taylor, S Klaeger, C Xu, ... Nature Communications 14 (1), 1851, 2023 | 15 | 2023 |
| Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry KM Phulphagar, C Ctortecka, ASV Jacome, S Klaeger, EK Verzani, ... Molecular & Cellular Proteomics 22 (6), 2023 | 14 | 2023 |
| Tumor infiltrating lymphocytes target HLA-I phosphopeptides derived from cancer signaling in colorectal cancer SA Penny, JG Abelin, SA Malaker, PT Myers, AZ Saeed, LG Steadman, ... Frontiers in immunology 12, 723566, 2021 | 14 | 2021 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 12 | 2016 |
| What can ribo-seq, immunopeptidomics, and proteomics tell us about the noncanonical proteome? JR Prensner, JG Abelin, LW Kok, KR Clauser, JM Mudge, J Ruiz-Orera, ... Molecular & Cellular Proteomics 22 (9), 2023 | 11 | 2023 |
| MONTE enables serial immunopeptidome, ubiquitylome, proteome, phosphoproteome, acetylome analyses of sample-limited tissues JG Abelin, EJ Bergstrom, HB Taylor, KD Rivera, S Klaeger, ME Olive, ... bioRxiv, 2021.06. 22.449417, 2021 | 10 | 2021 |
